DK0689458T3 - Plaster med aktiv bestanddel til afgivelse af estradiol på huden - Google Patents
Plaster med aktiv bestanddel til afgivelse af estradiol på hudenInfo
- Publication number
- DK0689458T3 DK0689458T3 DK94909117T DK94909117T DK0689458T3 DK 0689458 T3 DK0689458 T3 DK 0689458T3 DK 94909117 T DK94909117 T DK 94909117T DK 94909117 T DK94909117 T DK 94909117T DK 0689458 T3 DK0689458 T3 DK 0689458T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- active substance
- estradiol
- skin
- ch2oh
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4309830A DE4309830C1 (de) | 1993-03-26 | 1993-03-26 | Wirkstoffpflaster für die Abgabe von Estradiol an die Haut |
PCT/EP1994/000670 WO1994022481A1 (fr) | 1993-03-26 | 1994-03-07 | Emplatre de matiere active pour administration d'oestradiol par la peau |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0689458T3 true DK0689458T3 (da) | 1999-08-09 |
Family
ID=6483909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94909117T DK0689458T3 (da) | 1993-03-26 | 1994-03-07 | Plaster med aktiv bestanddel til afgivelse af estradiol på huden |
Country Status (23)
Country | Link |
---|---|
US (1) | US5686098A (fr) |
EP (1) | EP0689458B1 (fr) |
JP (1) | JPH08508266A (fr) |
KR (1) | KR960700754A (fr) |
AT (1) | ATE173636T1 (fr) |
AU (1) | AU681383B2 (fr) |
CA (1) | CA2156746A1 (fr) |
CZ (1) | CZ287544B6 (fr) |
DE (2) | DE4309830C1 (fr) |
DK (1) | DK0689458T3 (fr) |
ES (1) | ES2127384T3 (fr) |
FI (1) | FI954497A (fr) |
GR (1) | GR3029387T3 (fr) |
HR (1) | HRP940213A2 (fr) |
HU (1) | HU220861B1 (fr) |
IL (1) | IL109084A (fr) |
NO (1) | NO953792L (fr) |
NZ (1) | NZ262418A (fr) |
PL (1) | PL173547B1 (fr) |
SK (1) | SK280246B6 (fr) |
WO (1) | WO1994022481A1 (fr) |
YU (1) | YU14394A (fr) |
ZA (1) | ZA941987B (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4429664C2 (de) * | 1994-08-20 | 1997-09-11 | Lohmann Therapie Syst Lts | Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung |
DE4429663C2 (de) * | 1994-08-20 | 1997-09-11 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Hydrolyseschutz |
DE19526864A1 (de) * | 1995-07-22 | 1997-01-23 | Labtec Gmbh | Hormonpflaster |
FR2749586B1 (fr) * | 1996-06-11 | 1998-08-07 | Hoechst Marion Roussel Inc | Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments |
DE19701949A1 (de) * | 1997-01-13 | 1998-07-16 | Jenapharm Gmbh | Transdermales therapeutisches System |
DE19702314C2 (de) * | 1997-01-23 | 2000-12-21 | Lohmann Therapie Syst Lts | Ablösbare Schutzfolie für wirkstoffhaltige, insbesondere selbstklebende Pflastersysteme |
FR2776191B1 (fr) * | 1998-03-23 | 2002-05-31 | Theramex | Composition hormonale topique a effet systemique |
DE19828273B4 (de) * | 1998-06-25 | 2005-02-24 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren |
FR2789586A1 (fr) * | 1999-02-16 | 2000-08-18 | Synthelabo | Composition pharmaceutique pour administration transmucosale balanique d'alfuzosine |
DE10008128A1 (de) * | 2000-02-22 | 2001-08-23 | Bayer Ag | Endoparasitizide Mittel |
DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
FR2869232B1 (fr) * | 2004-04-21 | 2007-09-21 | Gattefosse Sas Soc Par Actions | Nouveaux excipients pharmaceutiques ou cosmetiques a base d'acetals cyliques |
DE102004062182B4 (de) * | 2004-12-20 | 2007-06-06 | Bayer Schering Pharma Ag | Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff |
US20060134188A1 (en) * | 2004-12-20 | 2006-06-22 | Hans-Peter Podhaisky | Transdermal pharmaceutical preparation with a progesterone A-specific ligand (PRASL) as active ingredient |
FR2912149B1 (fr) * | 2007-02-05 | 2012-10-12 | Rhodia Poliamida E Especialidades Ltda | Utilisation de derives de dioxolane dans des systemes de revetement et formulation de systeme de revetement |
CA2696632C (fr) * | 2007-08-17 | 2014-05-27 | Arcion Therapeutics, Inc. | Formulations anesthesiques locales a concentration elevee |
DE102008059054A1 (de) * | 2008-11-26 | 2010-05-27 | Otto Bock Pur Life Science Gmbh | Polyurethanpflaster für die transdermale Applikation von Wirkstoffen und Verfahren zu dessen Herstellung |
JP5639208B2 (ja) * | 2013-02-22 | 2014-12-10 | ロディア・ポリアミダ・エ・エスペシアリダデス・リミターダRhodia Poliamida E Especialidades Ltda | コーティング系におけるジオキソラン誘導体の使用及びコーティング系配合物 |
JP5576523B2 (ja) * | 2013-02-22 | 2014-08-20 | ロディア・ポリアミダ・エ・エスペシアリダデス・リミターダ | コーティング系におけるジオキソラン誘導体の使用及びコーティング系配合物 |
CN116157211B (zh) * | 2020-08-26 | 2024-03-08 | 中国涂料株式会社 | 低voc涂料组合物、涂膜和具有涂膜的基材以及它们的制造方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1385914A (en) * | 1971-10-19 | 1975-03-05 | Wigglesworth Ltd | Compositions having bactericidal activity |
BE795226A (fr) * | 1972-02-11 | 1973-08-09 | Syntex Corp | Vehicule pour pommade contenant du dimethyl-2,2dioxolane-1,3 methanol-4 |
US4818540A (en) * | 1985-02-25 | 1989-04-04 | Rutgers, The State University Of New Jersey | Transdermal fertility control system and process |
US5023084A (en) * | 1986-12-29 | 1991-06-11 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
US4906169A (en) * | 1986-12-29 | 1990-03-06 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
US4746515A (en) * | 1987-02-26 | 1988-05-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
ATE101511T1 (de) * | 1988-08-02 | 1994-03-15 | Ciba Geigy Ag | Mehrschichtiges pflaster. |
WO1991005529A1 (fr) * | 1989-10-13 | 1991-05-02 | Watson Laboratories, Inc. | Systemes d'apport de medicaments et matrice prevue a cet effet |
SE8904296D0 (sv) * | 1989-12-21 | 1989-12-21 | Pharmacia Ab | Transdermal system |
-
1993
- 1993-03-26 DE DE4309830A patent/DE4309830C1/de not_active Expired - Fee Related
-
1994
- 1994-03-07 WO PCT/EP1994/000670 patent/WO1994022481A1/fr active IP Right Grant
- 1994-03-07 DE DE59407345T patent/DE59407345D1/de not_active Expired - Fee Related
- 1994-03-07 CA CA002156746A patent/CA2156746A1/fr not_active Abandoned
- 1994-03-07 SK SK1206-95A patent/SK280246B6/sk unknown
- 1994-03-07 PL PL94310555A patent/PL173547B1/pl unknown
- 1994-03-07 EP EP94909117A patent/EP0689458B1/fr not_active Expired - Lifetime
- 1994-03-07 CZ CZ19952489A patent/CZ287544B6/cs unknown
- 1994-03-07 ES ES94909117T patent/ES2127384T3/es not_active Expired - Lifetime
- 1994-03-07 NZ NZ262418A patent/NZ262418A/en unknown
- 1994-03-07 US US08/530,107 patent/US5686098A/en not_active Expired - Fee Related
- 1994-03-07 DK DK94909117T patent/DK0689458T3/da active
- 1994-03-07 KR KR1019950704010A patent/KR960700754A/ko not_active Application Discontinuation
- 1994-03-07 AU AU62083/94A patent/AU681383B2/en not_active Ceased
- 1994-03-07 HU HU9502794A patent/HU220861B1/hu not_active IP Right Cessation
- 1994-03-07 AT AT94909117T patent/ATE173636T1/de not_active IP Right Cessation
- 1994-03-07 JP JP6521587A patent/JPH08508266A/ja active Pending
- 1994-03-22 ZA ZA941987A patent/ZA941987B/xx unknown
- 1994-03-22 IL IL10908494A patent/IL109084A/en active IP Right Grant
- 1994-03-25 YU YU14394A patent/YU14394A/sh unknown
- 1994-03-25 HR HRP4309830.4A patent/HRP940213A2/hr not_active Application Discontinuation
-
1995
- 1995-09-22 FI FI954497A patent/FI954497A/fi unknown
- 1995-09-25 NO NO953792A patent/NO953792L/no not_active Application Discontinuation
-
1999
- 1999-02-12 GR GR990400471T patent/GR3029387T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH08508266A (ja) | 1996-09-03 |
HRP940213A2 (en) | 1998-02-28 |
EP0689458A1 (fr) | 1996-01-03 |
SK280246B6 (sk) | 1999-10-08 |
HUT73425A (en) | 1996-07-29 |
NO953792D0 (no) | 1995-09-25 |
ATE173636T1 (de) | 1998-12-15 |
WO1994022481A1 (fr) | 1994-10-13 |
GR3029387T3 (en) | 1999-05-28 |
FI954497A0 (fi) | 1995-09-22 |
ZA941987B (en) | 1995-04-05 |
CA2156746A1 (fr) | 1994-10-13 |
PL310555A1 (en) | 1995-12-27 |
IL109084A (en) | 1996-12-05 |
CZ248995A3 (en) | 1996-03-13 |
IL109084A0 (en) | 1994-06-24 |
YU14394A (sh) | 1997-01-08 |
HU9502794D0 (en) | 1995-11-28 |
AU6208394A (en) | 1994-10-24 |
PL173547B1 (pl) | 1998-03-31 |
DE59407345D1 (de) | 1999-01-07 |
AU681383B2 (en) | 1997-08-28 |
HU220861B1 (en) | 2002-06-29 |
SK120695A3 (en) | 1997-02-05 |
ES2127384T3 (es) | 1999-04-16 |
EP0689458B1 (fr) | 1998-11-25 |
NO953792L (no) | 1995-09-25 |
US5686098A (en) | 1997-11-11 |
CZ287544B6 (en) | 2000-12-13 |
FI954497A (fi) | 1995-09-22 |
KR960700754A (ko) | 1996-02-24 |
NZ262418A (en) | 1996-08-27 |
DE4309830C1 (de) | 1994-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0689458T3 (da) | Plaster med aktiv bestanddel til afgivelse af estradiol på huden | |
DE59405920D1 (de) | Wirkstoffhaltiges pflaster | |
FI953533A (fi) | Transdermaalinen terapeuttinen järjestelmä, jossa on galantamiinia vaikuttavana aineena | |
DK0802789T3 (da) | Estradiolholdigt plaster | |
CZ102295A3 (en) | Plaster for transdermal application of volatile, pharmaceutically active chemically basic active compounds and process for preparing thereof | |
YU2594A (sh) | Flaster koji sadrži nitroglicerin i postupak za njegovo dobijanje | |
ES2105334T3 (es) | Sistema terapeutico percutaneo para la administracion de fisostigmina en la piel y el procedimiento para su obtencion. |